Stoxx Europe 50
4 590,82
|
-9,08
|
-0,20 %
|
Analysen zu Stoxx Europe 50-Werten
06.10.23 | BP Buy | Goldman Sachs Group Inc. | |
06.10.23 | Shell Buy | Jefferies & Company Inc. | |
06.10.23 | Shell Outperform | RBC Capital Markets | |
06.10.23 | ASML NV Buy | Jefferies & Company Inc. | |
06.10.23 | Rio Tinto Neutral | UBS AG | |
05.10.23 | Deutsche Telekom Buy | UBS AG | |
05.10.23 | SAP Add | Baader Bank | |
05.10.23 | SAP Add | Baader Bank | |
05.10.23 | Sanofi Sell | Deutsche Bank AG | |
05.10.23 | National Grid Neutral | UBS AG | |
05.10.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
05.10.23 | Novartis Neutral | JP Morgan Chase & Co. | |
05.10.23 | BAT Neutral | JP Morgan Chase & Co. | |
05.10.23 | Unilever Underweight | JP Morgan Chase & Co. | |
05.10.23 | L'Oréal Neutral | JP Morgan Chase & Co. | |
05.10.23 | Diageo Overweight | JP Morgan Chase & Co. | |
05.10.23 | AB InBev Overweight | JP Morgan Chase & Co. | |
05.10.23 | Novartis Buy | Deutsche Bank AG | |
05.10.23 | Air Liquide Buy | Deutsche Bank AG | |
05.10.23 | SAP Buy | UBS AG | |
04.10.23 | Novartis Neutral | UBS AG | |
04.10.23 | EssilorLuxottica Neutral | UBS AG | |
04.10.23 | AstraZeneca Hold | Deutsche Bank AG | |
04.10.23 | Novartis Buy | Deutsche Bank AG | |
04.10.23 | AB InBev Overweight | Barclays Capital | |
04.10.23 | AB InBev Outperform | RBC Capital Markets | |
04.10.23 | ABB Outperform | RBC Capital Markets | |
04.10.23 | EssilorLuxottica Overweight | JP Morgan Chase & Co. | |
04.10.23 | Intesa Sanpaolo Overweight | JP Morgan Chase & Co. | |
04.10.23 | TotalEnergies Buy | Jefferies & Company Inc. | |
04.10.23 | BP Hold | Jefferies & Company Inc. | |
04.10.23 | RELX Buy | Goldman Sachs Group Inc. | |
03.10.23 | Rheinmetall Buy | Deutsche Bank AG | |
03.10.23 | Novartis Buy | Deutsche Bank AG | |
03.10.23 | Nestlé Buy | Deutsche Bank AG | |
03.10.23 | AB InBev Buy | Deutsche Bank AG | |
03.10.23 | Hermès Buy | UBS AG | |
03.10.23 | LVMH Moet Hennessy Louis Vuitton Buy | UBS AG | |
03.10.23 | ABB Equal Weight | Barclays Capital | |
03.10.23 | Sanofi Overweight | JP Morgan Chase & Co. |